Inspire Medical Systems, Inc. (INSP)
After hours:
Chart Events
Performance Outlook
| Previous Close | 170.68 |
| Open | 167.94 |
| Bid | 162.00 x 1200 |
| Ask | 250.00 x 1000 |
| Day's Range | 164.49 - 172.23 |
| 52 Week Range | 142.74 - 286.29 |
| Volume | |
| Avg. Volume | 261,431 |
| Market Cap | 4.94B |
| Beta (5Y Monthly) | 1.56 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.55 |
| Earnings Date | Oct 31, 2022 - Nov 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 282.78 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for INSP
Related Research
- Inspire Medical Systems, Inc.RMBS: What does Argus have to say about RMBS?RAMBUS INC has an Investment Rating of HOLD; a target price of $27.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.RatingFair ValueEconomic Moat4 days agoArgus Research
- Barrons.com
Healthcare Learned a Lot From Covid. 12 Ways to Invest Now.
From biotech to managed care, companies are tackling new challenges in science and business. Our healthcare roundtable experts pick 12 stocks that could win.
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Updates from International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings
MINNEAPOLIS, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today key updates from the International Surgical Sleep Society (ISSS) and American Academy of Otolaryngology (AAO-HNSF) meetings which took place in Philadelphia September 9-14th. “We were excited to return to in-person co
- Zacks
Inspire (INSP) Stock Jumps 5.6%: Will It Continue to Soar?
Inspire (INSP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
